Benzinga's Top #PreMarket Gainers
November 15, 2013 at 08:16 AM EST
Vanda Pharmaceuticals (NASDAQ: VNDA ) shares gained 17.48% to $15.32 in the pre-market after the FDA Advisory Committee recommended the approval of HETLIOZ. Agilent Technologies (NYSE: A ) surged 6.25% to $53.70 in the pre-market session after the company reported an upbeat Q4 profit. Tile Shop Holdings (NASDAQ: